期刊文献+

正电子发射计算机断层显像在中枢神经系统药物研发中的应用

The application of positron emission tomography in the research and development of central nervous system drugs
下载PDF
导出
摘要 正电子发射型计算机断层显像技术(positron emission tomography,PET)在中枢神经系统(CNS)药物研发中发挥重要作用。PET可以定量研究CNS药物在脑组织体液中的生物分布,药代动力学,与靶点相互作用,提供药物浓度与受体占有率的定量关系。本综述总结了PET在CNS药物研发中的定量分析手段,包括药代动力学分析以及受体占有率分析中常用的方法与数学公式。同时,本综述也总结了PET在CNS新药研发中的应用,为后续CNS的新药研发提供新的思路与方向。 Positron emission tomography(PET)now plays an important role in the research and development(R&D)of central nervous system(CNS)drugs.PET could characterize the biodistribution,pharmacokinetics,and receptor binding of CNS drugs quantitatively.The present review summarized the quantitative methods of PET used in the pharmacokinetics and receptor occupancy analysis of CNS drugs.Moreover,the present review listed various applications of PET supporting R&D of CNS drugs,which could provide a new direction for the R&D of CNS drugs.
作者 李思泽 黄琪 武晓捷 王少楠 管一晖 谢芳 张菁 LI Size;HUANG Qi;WU Xiaojie;WANG Shaonan;GUAN Yihui;XIE Fang;ZHANG Jing(Phase I Clinical Research Center,Huashan Hospital,Fudan University,Shanghai 200040,China;Department of Nuclear Medicine&PET Center,Huashan Hospital,Fudan University,Shanghai 200235,China;National Center for Neurological Disorders(Huashan),Shanghai 200040,China;Translational Medicine&Clinical Pharmacology,Boehringer Ingelheim,The Chinese Market,Shanghai 200040,China;Institue of Antibiotics,Huashan Hospital,Fudan University,Shanghai 200040,China)
出处 《中国临床药理学与治疗学》 CAS CSCD 北大核心 2024年第3期316-327,共12页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 科技部“重大新药创制”科技重大专项(2017ZX09304005)。
关键词 正电子发射型计算机断层扫描 中枢神经系统 新药研发 药代动力学 受体占有率 positron emission tomography central nervous system the research and development of new drugs pharmacokinetics receptor occupancy
  • 相关文献

参考文献2

二级参考文献26

  • 1李广义,李军,刘松涛,刘庆伟.PET/CT成像原理概述[J].医学影像学杂志,2004,14(8):681-684. 被引量:16
  • 2尚辉.PET/CT的原理及临床应用[J].医疗设备信息,2005,20(11):20-20. 被引量:12
  • 3王亚丽.PET核医学成像原理分析[J].科技情报开发与经济,2007,17(18):162-163. 被引量:11
  • 4容丹辉.PET设备原理、特点及技术进展[J].医疗装备,2007,20(8):23-24. 被引量:6
  • 5[1]Budinger TF. PET instrumentation: what are the limits?[J]. Semin Nucl Med,1998,28:247-267.
  • 6[2]Townsend DW, Beyer T, Kinahan PE, et al. The SMART scanner: a combined PET/C T tomograph for clinical oncology[J]. IEEE Nucl Sci Symp Med Imaging Conf Rec,1998,2:1170-1174.
  • 7[3]Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scann er for clinical oncology[J]. Nucl Med, 2000,41:1369-1379.
  • 8[4]Beyer T, Watson CC, Meltzer CC. A premium dual modality PET/ CT tomograph for clinical oncology[J].Electromedica, 2001,2:120-126.
  • 9[5]Kinahan PE, Townsend DW, Beyer T, Attenuation correction for a combined 3D PET/CT scanner[J]. Med Phys,1998,25:2046-2053.
  • 10[6]Riddell C, Carson RE, Carrasquillo JA, et al. Noise reductio n in oncology FD G PET images by iterative reconstruction: a quantitative assessment[J]. Nu cl Med,2001,42:1316-1323.

共引文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部